- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01208376
Prevalence of Liver Fibrosis and Progression of Liver Fibrosis
December 19, 2016 updated by: Helen Kovari-Kramer
Prevalence of Liver Fibrosis and Progression of Liver Fibrosis in HIV-infected, Hepatitis C (HCV) and Hepatitis B (HBV) Seronegative Patients With Chronic Alanine Aminotransferase (ALT) Elevation
Little is known about the clinical significance of chronic alanine aminotransferase (ALT) elevation in HIV-infected patients without hepatitis B and C coinfection.
Study aim is first to evaluate the prevalence of liver fibrosis and cirrhosis in HIV-infected patients with chronic ALT elevation and no chronic viral hepatitis using non-invasive diagnostic tests and second to find associated factors with significant fibrosis and cirrhosis.
In a second longitudinal part we intend to assess fibrosis progression within 1 and 3 years.
Study Overview
Status
Unknown
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
195
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Zurich, Switzerland
- University Hospital Zurich
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
HIV-infected, hepatitis B and C seronegative Patients With Chronic alanine aminotransferase (ALT) Elevation
Description
Inclusion criteria: Case patients:
- HIV-1 infection
- no hepatitis B and C coinfection
- chronic alanine aminotransferase (ALT) elevation after 1.1.2007
- signed informed consent
- no other common cause of liver disease
Control patients:
- HIV-infection
- no hepatitis B and C coinfection
- no ALT elevation after 1.1.2002, the date when ALT values were regularly collected in the Swiss HIV Cohort Study (SHCS)
- no known chronic liver disease
Exclusion criteria: please see inclusion criteria
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Cross-Sectional
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
unexplained chronic ALT elevation
Case patients: HIV-infected, unexplained chronic alanine aminotransferase (ALT) elevation
|
Fibroscan and Serum Fibrose-marker
Other Names:
|
always normal ALT
Control patients: HIV-infected, always normal ALT values
|
Fibroscan and Serum Fibrose-marker
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Liverfibrosis
Time Frame: 3 years
|
3 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2010
Primary Completion (Anticipated)
August 1, 2018
Study Completion (Anticipated)
August 1, 2018
Study Registration Dates
First Submitted
September 22, 2010
First Submitted That Met QC Criteria
September 22, 2010
First Posted (Estimate)
September 23, 2010
Study Record Updates
Last Update Posted (Estimate)
December 20, 2016
Last Update Submitted That Met QC Criteria
December 19, 2016
Last Verified
May 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SHCS 625
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HIV Infection and Chronic Alanine Aminotransferase Elevation
-
Hospices Civils de LyonNot yet recruiting
-
Southeast University, ChinaCompletedChronic Hepatitis B | Pregnancy Complications | High Viral Load | Elevated Alanine Aminotransferase LevelsChina
-
Yale UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedHypertriglyceridemia | Steatohepatitis | Non Alcoholic Fatty Liver Disease | Alanine Aminotransferase, Plasma Level of, Quantitative Trait Locus 1United States
-
Objectif Recherche Vaccins SIDAFondation Bettencourt-SchuellerCompleted
-
Federal University of São PauloFundação de Amparo à Pesquisa do Estado de São Paulo; Conselho Nacional de... and other collaboratorsCompletedHIV | Chronic InfectionBrazil
-
Fundacion SEIMC-GESIDAViiV HealthcareCompletedHCV Coinfection | Chronic HIV InfectionSpain
-
Pedro CahnMerck Sharp & Dohme LLCUnknownChronic Infection With HIVArgentina
-
ANRS, Emerging Infectious DiseasesUniversity College London Hospitals; Hospital Clinic of Barcelona; Imperial College... and other collaboratorsCompletedHIV-1-infectionFrance, United Kingdom, Switzerland
-
Nina BhardwajNational Institute of Allergy and Infectious Diseases (NIAID); National Institutes... and other collaboratorsCompletedHIV-1 Infected Adults With Chronic HIV-1 InfectionUnited States
-
National Institute of Diabetes and Digestive and...CompletedHIV Infection | Chronic Kidney FailureUnited States
Clinical Trials on Fibroscan
-
EchosensRecruitingSpleen; FibrosisSpain, Netherlands, Romania
-
Assiut UniversityNot yet recruiting
-
Assistance Publique - Hôpitaux de ParisTerminatedHepatitis, Viral, HumanFrance
-
Centre Hospitalier Universitaire DijonCompletedHepatic Steatosis | Pituitary Gland FailureFrance
-
Icahn School of Medicine at Mount SinaiNational Institutes of Health (NIH)CompletedNASH - Nonalcoholic Steatohepatitis | Steatosis of LiverUnited States
-
HaEmek Medical Center, IsraelTerminatedPatients With Fatty Liver DiseaseIsrael
-
University of AarhusActive, not recruitingLiver Inflammation | Primary Biliary CirrhosisDenmark
-
King's College Hospital NHS TrustUnknownLiver Diseases | Pregnancy Disease
-
Chang Gung Memorial HospitalUnknown
-
Nantes University HospitalRecruiting